Search form

AAS President David Helfand reflects on some of the beginnings and endings relevant to the Society and its members as we head toward autumn.

NASA's Astrophysics Division invites nominations for new Cosmic Origins Program Analysis Group (COPAG) Executive Committee members. Self nominations are welcome. Deadline: 20 September.

Deadlines are just around the corner to register and make hotel reservations for the 45th annual meeting of the AAS Division for Planetary Sciences, 6-11 October 2013, in Denver, Colorado.

The plan for institutional representatives described by AAS President David Helfand last April is now being implemented. Volunteers are welcome! Sign up today!

The Sloan Digital Sky Survey III announces its tenth public data release (DR10), featuring the first measurements from the APOGEE spectrograph and new data from the ongoing BOSS program.

Offered free to all members, the annual AAS Wall Calendar highlights important astronomical events month by month. The AAS seeks sponsors and key dates and deadlines for the 2014 edition. New this year: "Buy a Birthday!" Deadline: 1 September.

With Executive Officer Kevin Marvel on sabbatical, the other managers on the AAS staff will take turns writing this column. First up: CFO Kelly Clark, who writes about our recent office relocation.

The UNBSSI is a long-term effort for the development of astronomy and space science through regional and international cooperation on a worldwide basis, particularly in developing nations. A full report on a series of workshops held from 1991 to 2012 is now available.

The Kepler project office at NASA's Ames Research Center has released an open solicitation for community input for alternate science investigations that may be performed using Kepler and are consistent with its probable two-reaction-wheel performance.

The Golden Goose Award celebrates scientists whose federally funded research seemed odd or obscure but turned out to have a significant, positive impact on society. The latest recipient is a physician whose study of Gila monster venom led to a drug that protects diabetics from blindness, kidney failure, and nerve damage.